Articles

Pathogenetically determined approaches to the diagnosis and treatment of polyneropathy
Published in the journal «International Journal of Neurology» Vol 16 № 8’2020
Use of a metabolic drug in the complex therapy of patients with open-angle glaucoma
Published in a journal «Ophthalmology. Eastern Europe» Vol 10 № 3’2020
Pathogenetic treatment of patients with chronic viral hepatitis with severe liver fibrosis: aspects of UDCA application
Comparative study of the use of balanced COX-1,2 inhibitors in thyroid surgery
Published in the journal «Pain, Anaesthesia and Intensive Care» № 2’2020
Topical forms of diclofenac: effective treatment of osteoarthritis
Published in the thematic issue «Neurology, Psychiatry, Psychotherapy» № 1 (52)’2020
Application of the infusion form of L-carnitine in the complex treatment of patients with stage III chronic kidney disease
Published in the journal «Medical Business» № 1-2’2018
Macrolides: Significance and Safety for the Treatment of Pneumonia
Mitochondrial dysfunction in neurodegenerative disorders: from pathogenesis to therapy
Published in a journal «International Journal of Neurology» Vol 16 № 4’2020
The effectiveness of a combination of physiotherapeutic methods with local forms of non-steroidal anti-inflammatory drugs in the complex treatment of pain in rheumatology
Published in a journal «Pain Medicine» Vol 3 № 1’2018
The incidence of bacterial conjunctivitis and the antibacterial activity of drugs in their treatment
Published in the journal «Ophthalmology. Eastern Europe» Vol 9 № 4’2019

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design